Circulating Zika and dengue IgA-NS1 marks early postnatal exposure without significant association with congenital Zika syndrome-related microcephaly

Clicks: 5
ID: 337968
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #495 of 503 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 503 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Elevated preexisting maternal IgG-NS1 to DENV, rather than to ZIKV, has been associated with a reduced risk of microcephaly in congenital Zika syndrome (CZS), suggesting a protective role. While serological analysis of IgG and IgM has physiological limitations in infants, IgA-NS1 represents a marker of host exposure to orthoflavivirus, as it is not transferred transplacentally and reflects early active immune responses. This study evaluated circulating IgA-NS1 responses to ZIKV and DENV in mothers and infants prenatally exposed to ZIKV in southern Colombia, a dengue hyperendemic region. Methods In this multicentric study, we analyzed 164 mother-infant pairs with confirmed gestational ZIKV exposure during the Colombia 2015-2016 epidemic. Using optimized ELISAs with well-characterized clinical samples, we simultaneously assessed circulating IgA-NS1 responses against ZIKV and DENV1-4. Neurological outcomes were evaluated through pediatric follow-up to determine associations between IgA-NS1 and CZS-related microcephaly. Results IgA-NS1 ELISAs for ZIKV and DENV1-4 achieved sensitivity/specificity of 94%/97% and 86%/85%, respectively. DENV-exposed samples showed 26% cross-reactivity against ZIKV NS1. There was no evidence of placental transfer, and IgA-NS1 levels for ZIKV and DENV were comparable between mothers and infants with or without CZS-related microcephaly. However, circulating ZIKV and DENV IgA-NS1 increased postnatally and were higher in older children. Conclusion While circulating IgA-NS1 serves as a promising postnatal marker of orthoflavivirus exposure in infants due to its stability and lack of placental transfer, it does not appear to contribute to protection against severe CZS outcomes. These findings demonstrate that protective NS1-mediated immunity against microcephaly may be isotype-dependent.
Reference Key
openalex_W7224992489 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag540
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.